The Future of Sleeve Gastrectomy
Open Access
- 1 January 2016
- journal article
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Endocrinology
- Vol. 12 (1)
- https://doi.org/10.17925/ee.2016.12.01.37
Abstract
The International Diabetes Federation has recently published a position statement on bariatric surgery. Facing a global diabetes crisis, it has added various types of surgery on the gastrointestinal tract as powerful options among the armamentarium to normalise glycaemia, avoid regular medications and decrease costs in severely obese patients. Laparoscopic sleeve gastrectomy has been shown to be effective for the treatment of type 2 diabetes, with extremely low mortality and acceptable morbidity. It decreases caloric consumption, modifies gut hormones, changes gastric emptying, and lowers glycaemia. In the long term, if recurrences in weight or diabetes occur, it can be converted to a duodenal switch, potentially reaching 90% of patients with partial or complete remission.Keywords
This publication has 5 references indexed in Scilit:
- Effect of sleeve gastrectomy on type 2 diabetes as an alternative to Roux-en-Y gastric bypass: a better long-term strategySurgery for Obesity and Related Diseases, 2015
- Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patientsSurgery for Obesity and Related Diseases, 2015
- Long-Term Metabolic Outcomes 5 to 20 Years After Biliopancreatic DiversionObesity Surgery, 2015
- FXR is a molecular target for the effects of vertical sleeve gastrectomyNature, 2014
- Early Experience with Two-Stage Laparoscopic Roux-en-Y Gastric Bypass as an Alternative in the Super-Super Obese PatientObesity Surgery, 2003